www.theheart.or...
Dr Bertram Pitt (University of Michigan, Ann Arbor) discusses the effect of eplerenone vs placebo on cardiovascular mortality or heart-failure hospitalization in subjects with NYHA class 2 chronic systolic heart failure: An analysis of the high-risk groups in the study population with Dr Robert Byrne (German Heart Center, Munich).
Filmed during ESC 2011 in Paris on August 28.
Негізгі бет EMPHASIS-HF with Dr Bertram Pitt
No video
Пікірлер: 1